Subcutaneous fistulae in a patient with femoral hypoplasia due to actinomyces europaeus and actinomyces turicensis

Infection

Volumn 37, Issue 3, 2009, Pages 289-291

  Zautner, A E ^a   Schmitz, S ^a   Aepinus, C ^a   Schmialek, A ^b   Podbielski, A ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b Clinic for Diagnostic Radiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; RIBOSOME RNA; RNA 16S; VANCOMYCIN; ANTIFUNGAL AGENT; BACTERIAL RNA;

ACTINOMYCES; ACTINOMYCES EUROPAEUS; ACTINOMYCES TURICENSIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; EDEMA; EXCISION; FEMORAL ARTERY; FEMUR HYPOPLASIA; FISTULA; GENE SEQUENCE; HUMAN; HYPOPLASIA; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PAIN; SEQUENCE HOMOLOGY; SUBCUTANEOUS FISTULA; SUBCUTANEOUS FISTULAE; TREATMENT DURATION; TREATMENT OUTCOME; ACTINOMYCOSIS; CLASSIFICATION; CONGENITAL MALFORMATION; FEMUR; IMMUNOCOMPETENCE; ISOLATION AND PURIFICATION; KNEE; LEG MALFORMATION; MICROBIOLOGY; SOFT TISSUE INFECTION; SURGICAL INFECTION;

ACTINOMYCES; ACTINOMYCOSIS; ANTIFUNGAL AGENTS; CEFUROXIME; FEMUR; FISTULA; HUMANS; IMMUNOCOMPETENCE; KNEE JOINT; LOWER EXTREMITY DEFORMITIES, CONGENITAL; MALE; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SOFT TISSUE INFECTIONS; SURGICAL WOUND INFECTION; VANCOMYCIN; YOUNG ADULT;

EID: 67650221569     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-7392-9     Document Type: Article

References (8)

1. G. Funke N. Alvarez C. Pascual E. Falsen E. Akervall L. Sabbe L. Schouls N. Weiss M.D. Collins 1997 Actinomyces europaeus sp. nov., isolated from human clinical specimens Int J Syst Bacteriol 47 687 692 (Pubitemid 27327756)
2. V. Hall G.L. O'Neill J.T. Magee B.I. Duerden 1999 Development of amplified 16S ribosomal DNA restriction analysis for identification of Actinomyces species and comparison with pyrolysismass spectrometry and conventional biochemical tests J Clin Microbiol 37 2255 2261
3. V. Hall P.R. Talbot S.L. Stubbs B.I. Duerden 2001 Identification of clinical isolates of Actinomyces species by amplified 16S ribosomal DNA restriction analysis J Clin Microbiol 39 3555 3562 (Pubitemid 32954501)
4. J. Wüst S. Stubbs N. Weiss G. Funke M.D. Collins 1995 Assignment of Actinomyces pyogenes-like (CDC coryneform group E) bacteria to the genus Actinomyces as Actinomyces radingae sp. nov. and Actinomyces turicensis sp. nov Lett Appl Microbiol 20 76 81
5. J.E. Clarridge 3rd Q. Zhang 2002 Genotypic diversity of clinical Actinomyces species: phenotype, source, and disease correlation among genospecies J Clin Microbiol 40 3442 3448
6. L.J. Sabbe D. Van De Merwe L. Schouls A. Bergmans M. Vaneechoutte P. Vandamme 1999 Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus J Clin Microbiol 37 8 13
7. P. Vandamme E. Falsen M. Vancanneyt M. Van Esbroeck D. Van de Merwe A. Bergens L. Schouls L. Sabbe 1998 Characterization of Actinomyces turicensis and Actinomyces radingae strains from human clinical samples Int J Syst Bacteriol 2 503 510
8. A.J. Smith V. Hall B. Thakker C.G. Gemmell 2005 Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents J Antimicrob Chemother 56 407 409